19-42326292-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001271938.2(MEGF8):​c.49G>C​(p.Val17Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MEGF8
NM_001271938.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.17

Publications

1 publications found
Variant links:
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
  • MEGF8-related Carpenter syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Carpenter syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.036642343).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEGF8NM_001271938.2 linkc.49G>C p.Val17Leu missense_variant Exon 1 of 42 ENST00000251268.11 NP_001258867.1 Q7Z7M0-1
MEGF8NM_001410.3 linkc.49G>C p.Val17Leu missense_variant Exon 1 of 41 NP_001401.2 Q7Z7M0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEGF8ENST00000251268.11 linkc.49G>C p.Val17Leu missense_variant Exon 1 of 42 5 NM_001271938.2 ENSP00000251268.5 Q7Z7M0-1
MEGF8ENST00000334370.8 linkc.49G>C p.Val17Leu missense_variant Exon 1 of 41 1 ENSP00000334219.4 Q7Z7M0-2
MEGF8ENST00000378073.5 linkc.-7037G>C 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 41 5 ENSP00000367313.4 F5GZG7
MEGF8ENST00000378073.5 linkc.-7037G>C 5_prime_UTR_variant Exon 1 of 41 5 ENSP00000367313.4 F5GZG7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
196808
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1410976
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
701932
African (AFR)
AF:
0.00
AC:
0
AN:
29296
American (AMR)
AF:
0.00
AC:
0
AN:
32408
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24248
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35432
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5482
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1093356
Other (OTH)
AF:
0.00
AC:
0
AN:
58198
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000829
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 30, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.49G>C (p.V17L) alteration is located in exon 1 (coding exon 1) of the MEGF8 gene. This alteration results from a G to C substitution at nucleotide position 49, causing the valine (V) at amino acid position 17 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.13
DANN
Benign
0.69
DEOGEN2
Benign
0.072
.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.53
T;T
M_CAP
Benign
0.0043
T
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.26
N;N
PhyloP100
-1.2
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
-0.39
N;N
REVEL
Benign
0.018
Sift
Benign
0.72
T;T
Sift4G
Benign
0.44
T;T
Polyphen
0.0
B;.
Vest4
0.070
MutPred
0.54
Loss of catalytic residue at V17 (P = 0.0408);Loss of catalytic residue at V17 (P = 0.0408);
MVP
0.13
MPC
0.37
ClinPred
0.029
T
GERP RS
-5.9
Varity_R
0.036
gMVP
0.11
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749510496; hg19: chr19-42830444; API